Cangrelor's effects on heart function during heart procedures
Official title: Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention
Run by Federico II University · NCT06089577 · Data updated 2026-11-12
This study is testing if a new heart medication called Cangrelor can better protect the small blood vessels in the heart during procedures for patients with chronic heart issues compared to the usual treatment.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Federico II University Academic / other |
| Locations | 2 sites (Ferrara and 1 other locations) |
| Status | Recruiting |
| Started | November 1, 2023 |
| Main results expected | October 2025 |
| Study ends | October 2026 |
| Registry record updated | March 13, 2025 |
| Trial ID | NCT06089577 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with chronic coronary syndromes who are naive to P2Y12 inhibitors and require elective PCI for intermediate coronary artery stenoses.
✕Probably not a fit
Patients with acute coronary syndromes or those already on P2Y12 inhibitors will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of Cangrelor, an intravenous antiplatelet medication, on coronary microvascular dysfunction in patients with chronic coronary syndromes undergoing elective percutaneous coronary interventions (PCI). It compares the efficacy of Cangrelor to standard treatment with Clopidogrel in preventing microvascular damage during these procedures. Patients will be monitored for changes in coronary flow reserve and index of microcirculatory resistance before and after PCI. The goal is to determine if Cangrelor can provide better protection for the heart's microcirculation during these interventions.
Why it matters
Potential benefit: If successful, this study could lead to improved heart function and reduced symptoms for patients undergoing PCI.
How similar studies have gone: While the use of Cangrelor is established, this specific application in elective PCI for chronic coronary syndromes is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients; * Signed Informed Consent; * Chronic coronary syndromes; * P2Y12-inhibitors naive patients; * Elective PCI of a functionally significant (FFR ≤ 0.80) de-novo intermediate coronary artery stenoses in a major vessel; Exclusion Criteria: * Underaged patients; * Acute Conorary Syndromes; * Already on treatment with P2Y12-inhibitors; * Heart failure with severe reduction of the left ventricle ejection fraction (LVEF \< 30%); * Subtotal occlusion (diameter stenosis \> 90%) of the target lesion;
Where it's running
-
Division of Cardiology - Federico II University Hospital
Naples, Italy Recruiting -
Division of Cardiology, University Hospital of Ferrara
Ferrara, Italy Not yet recruiting
Study contacts
- Study coordinator: Luigi Di Serafino, MD, PhD
- Email: luigi.diserafino@unina.it
- Phone: +390817462235
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.